Video - Results from #10

Practical Aspects of Radioligand Therapy in the Clinic VL

Search

Patient Management and Operationalizing Lutetium-177–PSMA-617 for Metastatic Castration Resistant Prostate Cancer in the Clinic – Charlotte Manogue and Oliver Sartor Details Oliver Sartor, Medical Director of the Tulane Cancer Center and co-PI on the Phase III VISION trial, and Charlotte Manogue, Senior Clinical Research Coordinator at Tulane Cancer Center join Phillip Koo in a discussion on identifying the patients and managing the patient care process for treatment with radioligand therapy in the clinic. Biographies: Oliver Sartor, MD, CE and Bernadine Laborde Profe...
Establishing A Theranostics Clinic for Advanced Prostate Cancer – Kendra Harris and Charlotte Manogue Details Phillip Koo, Kendra Harris, Chair of Radiation Oncology, and Charlotte Manogue, Senior Clinical Research Coordinator discuss the process for establishing a theranostics clinic from the regulatory processes and obtaining radioactive materials license (RML) to obtaining clearance through the radiation safety committee. Together they demystify the processes required to establish a radioligand treatme...
The Stakeholders in Operationalizing an Integrated PSMA Imaging and Therapies Clinic - Kendra Harris Details Kendra Harris, Chair of Radiation Oncology at the Tulane Cancer Center joins Phillip Koo discussing the process and stakeholders required for developing and implementing a theranostics program, where there is an integration of PSMA imaging and PSMA targeted treatment in the radiation oncology (or nuclear medicine) clinic. The Tulane Cancer Center has successfully implemented a radioligand therapy...